Yayın:
Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older

Basit Görünüm
dc.contributor.buuauthorKanat, Ozkan
dc.contributor.buuauthorEvrensel, Türkkan
dc.contributor.buuauthorDemiray, Mutlu
dc.contributor.buuauthorKurt, Ender
dc.contributor.buuauthorGönüllü, Güzin
dc.contributor.buuauthorArslan, Murat
dc.contributor.buuauthorManavoǧlu, Osman
dc.contributor.buuauthorÖzkan, Hasan Atilla
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentİç Hastalıkları Ana Bilim Dalı
dc.contributor.orcid0000-0003-2501-3097
dc.contributor.orcid0000-0002-9732-5340
dc.contributor.researcheridM-8060-2019
dc.contributor.researcheridAAJ-1027-2021
dc.contributor.scopusid55881548500
dc.contributor.scopusid6603942124
dc.contributor.scopusid6603631569
dc.contributor.scopusid7006207332
dc.contributor.scopusid6506410014
dc.contributor.scopusid57197925370
dc.contributor.scopusid6602587152
dc.contributor.scopusid9250698600
dc.date.accessioned2023-11-22T08:43:01Z
dc.date.available2023-11-22T08:43:01Z
dc.date.issued2003-08-01
dc.identifier.citationKanat, O. vd. (2003). “Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older”. Lung Cancer, 41(2), 233-234.
dc.identifier.doi10.1016/S0169-5002(03)00199-5
dc.identifier.endpage234
dc.identifier.issn0169-5002
dc.identifier.issue2
dc.identifier.pubmed12871788
dc.identifier.scopus2-s2.0-0037829153
dc.identifier.startpage233
dc.identifier.urihttps://doi.org/10.1016/S0169-5002(03)00199-5
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0169500203001995
dc.identifier.urihttp://hdl.handle.net/11452/34974
dc.identifier.volume41
dc.identifier.wos000184525600014
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherElsevier
dc.relation.journalLung Cancer
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOncology
dc.subjectRespiratory system
dc.subject.emtreeAged
dc.subject.emtreeAnemia
dc.subject.emtreeBone marrow
dc.subject.emtreeBrain metastasis
dc.subject.emtreeCancer chemotherapy
dc.subject.emtreeCancer survival
dc.subject.emtreeChemoprophylaxis
dc.subject.emtreeClinical article
dc.subject.emtreeClinical practice
dc.subject.emtreeClinical trial
dc.subject.emtreeDisease course
dc.subject.emtreeFemale
dc.subject.emtreeGeriatrics
dc.subject.emtreeHeart function
dc.subject.emtreeHuman
dc.subject.emtreeHuman tissue
dc.subject.emtreeHydration
dc.subject.emtreeKidney function
dc.subject.emtreeLetter
dc.subject.emtreeLiver function
dc.subject.emtreeLung non small cell cancer
dc.subject.emtreeMale
dc.subject.emtreeMortality
dc.subject.emtreeNephrotoxicity
dc.subject.emtreeNeuropathy
dc.subject.emtreeNeutropenia
dc.subject.emtreePriority journal
dc.subject.emtreeThorax radiography
dc.subject.emtreeThrombocytopenia
dc.subject.emtreeToxicity
dc.subject.emtreeVomiting
dc.subject.emtreeAntiemetic agent
dc.subject.emtreeCisplatin
dc.subject.emtreeDexamethasone
dc.subject.emtreeEtoposide
dc.subject.emtreeInfusion fluid
dc.subject.emtreeMannitol
dc.subject.emtreeSerotonin 3 antagonist
dc.subject.wosOncology
dc.subject.wosRespiratory system
dc.titleCisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older
dc.typeLetter
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/İç Hastalıkları Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Dosyalar

Lisanslı seri

Şimdi gösteriliyor 1 - 1 / 1
Placeholder
Ad:
license.txt
Boyut:
1.71 KB
Format:
Item-specific license agreed upon to submission
Açıklama
İndir

Koleksiyonlar

İndeksli Yayınlar / Indexed Publications